GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » ABL Diagnostics (XPAR:ABLD) » Definitions » Equity-to-Asset

ABL Diagnostics (XPAR:ABLD) Equity-to-Asset : 0.41 (As of Jun. 2023)


View and export this data going back to 1989. Start your Free Trial

What is ABL Diagnostics Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. ABL Diagnostics's Total Stockholders Equity for the quarter that ended in Jun. 2023 was €6.71 Mil. ABL Diagnostics's Total Assets for the quarter that ended in Jun. 2023 was €16.37 Mil. Therefore, ABL Diagnostics's Equity to Asset Ratio for the quarter that ended in Jun. 2023 was 0.41.

The historical rank and industry rank for ABL Diagnostics's Equity-to-Asset or its related term are showing as below:

XPAR:ABLD' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.41   Med: 0.98   Max: 1
Current: 0.41

During the past 13 years, the highest Equity to Asset Ratio of ABL Diagnostics was 1.00. The lowest was 0.41. And the median was 0.98.

XPAR:ABLD's Equity-to-Asset is ranked worse than
55.69% of 677 companies
in the Healthcare Providers & Services industry
Industry Median: 0.46 vs XPAR:ABLD: 0.41

ABL Diagnostics Equity-to-Asset Historical Data

The historical data trend for ABL Diagnostics's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Diagnostics Equity-to-Asset Chart

ABL Diagnostics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.92 0.98 0.99 0.97 0.44

ABL Diagnostics Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.97 0.95 0.44 0.41

Competitive Comparison of ABL Diagnostics's Equity-to-Asset

For the Health Information Services subindustry, ABL Diagnostics's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ABL Diagnostics's Equity-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, ABL Diagnostics's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where ABL Diagnostics's Equity-to-Asset falls into.



ABL Diagnostics Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

ABL Diagnostics's Equity to Asset Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Equity to Asset (A: Dec. 2022 )=Total Stockholders Equity/Total Assets
=6.754/15.408
=0.44

ABL Diagnostics's Equity to Asset Ratio for the quarter that ended in Jun. 2023 is calculated as

Equity to Asset (Q: Jun. 2023 )=Total Stockholders Equity/Total Assets
=6.711/16.372
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Diagnostics  (XPAR:ABLD) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


ABL Diagnostics Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of ABL Diagnostics's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Diagnostics (XPAR:ABLD) Business Description

Traded in Other Exchanges
N/A
Address
72c, rue de, WOIPPY, Thionville, FRA, 57140
ABL Diagnostics is a diagnostic and medical software company. The group has focused on the development of software for collecting and processing medical databases, measuring the quality of care, diagnosing infectious diseases by genotyping, and providing decision support for doctors and nurses, virology and microbiology laboratories, and researchers dealing with patients suffering from chronic and complex diseases. It also develops, manufactures, and markets kits for clinical specimen collection.

ABL Diagnostics (XPAR:ABLD) Headlines

No Headlines